JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kempsford, R. D.
Right arrow Articles by Hearse, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kempsford, R. D.
Right arrow Articles by Hearse, D. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 269-279, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Protection of the immature heart. Temperature-dependent beneficial or detrimental effects of multidose crystalloid cardioplegia in the neonatal rabbit heart

RD Kempsford and DJ Hearse
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, England.

There are conflicting reports of the detrimental or beneficial effects of hypothermic cardioplegia in the immature heart. We therefore investigated the temperature-dependence of myocardial protection and the ability of single-dose and multidose infusions of cardioplegic solution to protect the immature heart during hypothermic ischemia. Isolated, working hearts (n = 6 per group) from neonatal rabbits (aged 7 to 10 days) were perfused aerobically (37.0 degrees C) for 20 minutes before infusion (2 minutes) with either perfusion fluid (noncardioplegia control) or St. Thomas' Hospital cardioplegic solution and ischemic arrest (for 4, 6, and 18 hours) at various temperatures between 10.0 degrees and 30.0 degrees C. Hearts arrested with cardioplegic solution received either one preischemic infusion only (single-dose cardioplegia) or repeated infusions at intervals of 60 or 180 minutes (multidose cardioplegia). Ischemic arrest with single-dose cardioplegia for 4 hours at 10.0 degrees, 20.0 degrees, 22.5 degrees, 25.0 degrees, 27.5 degrees, and 30.0 degrees C resulted in 96.0% +/- 4.3%, 96.6 +/- 2.5%, 87.0% +/- 3.8%, 71.8% +/- 10.0% (p less than 0.05 versus 10.0 degrees C group), 35.1% +/- 10.3% (p less than 0.01 versus 10.0 degrees C group), and 3.0% +/- 1.9% (p less than 0.04 versus 10.0 degrees C group) recovery of preischemic cardiac output, respectively. With 6 hours of ischemia at 20.0 degrees C, single-dose cardioplegia significantly (p less than 0.01) increased the recovery of cardiac output from 20.9% +/- 13.1% (control) to 76.4% +/- 4.4%, whereas multidose cardioplegia (infusion every 60 minutes) further increased recovery to 97.8% +/- 3.8% (p less than 0.01 versus control and single- dose cardioplegia). In contrast, after 6 hours of ischemia at 10.0 degrees C, cardiac output recovered to 93.4% +/- 1.2% (control) and 92.3% +/- 3.1% (single-dose cardioplegia), whereas multidose cardioplegia reduced recovery to 76.9% +/- 2.2% (p less than 0.01 versus both groups). This effect was confirmed after 18 hours of ischemia at 10.0 degrees C; single-dose cardioplegia significantly increased the recovery of cardiac output from 24.5% +/- 10.9% (control) to 62.9% +/- 13.3% (p less than 0.05), whereas multidose cardioplegia reduced recovery to 0.8% +/- 0.4% (p less than 0.01 versus single-dose cardioplegia) and elevated coronary vascular resistance from 8.90 +/- 0.56 mm Hg.min/ml (control) to 47.83 +/- 9.85 mm Hg.min/ml (p less than 0.01). This effect was not reduced by lowering the infusion frequency (from every 60 to every 180 minutes).(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
T. Murashita and K. Yasuda
The role of Na+/H+ exchange in the efficacy of multidose hypothermic cardioplegia in immature rabbit hearts
Eur J Cardiothorac Surg, December 1, 2002; 22(6): 944 - 950.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. G. Warner, M. G. Sheahan, S. M. Arebi, A. Banerjee, J. M. Deiss-Shrem, and K. R. Khabbaz
Proper timing of blood cardioplegia in infant lambs: superiority of a multiple-dose regimen
Ann. Thorac. Surg., March 1, 2001; 71(3): 872 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. N. Young, I. O. Choy, N. K. Silva, D. Y. Obayashi, and H. E. Barkan
ANTEGRADE COLD BLOOD CARDIOPLEGIA IS NOT DEMONSTRABLY ADVANTAGEOUS OVER COLD CRYSTALLOID CARDIOPLEGIA IN SURGERY FOR CONGENITAL HEART DISEASE
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1002 - 1009.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. E. Jessen, A. S. Abd-Elfattah, and A. S. Wechsler
Neonatal Myocardial Oxygen Consumption During Ventricular Fibrillation, Hypothermia, and Potassium Arrest
Ann. Thorac. Surg., January 1, 1996; 61(1): 82 - 87.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Karck, G. Ziemer, M. Zoeller, S. Schulte, K.-D. Juergens, H. Weisser, and A. Haverich
Protection of the chronic hypoxic immature rat heart during global ischemia
Ann. Thorac. Surg., March 1, 1995; 59(3): 699 - 706.
[Abstract] [PDF]


Home page
PerfusionHome page
Shu Tao, G. Calza, F. Lerzo, A. Virgone, N. Camassa, G. Panizzon, L. Brunelli, R. Moretti, P. Grasso, G. Ghiggeri, et al.
Activation of the intracellular glutathione system by oxydative stress during cardiopulmonary bypass and myocardial perfusion
Perfusion, January 1, 1995; 10(1): 45 - 50.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Saldanha and D. J. Hearse
Cardioplegia and vascular injuryDissociation of the effects of ischemia from those of the cardioplegic solution
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 279 - 290.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. J. Kohman and L. J. Veit
Single-dose versus multidose cardioplegia in neonatal hearts
J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1512 - 1518.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. E. Baker, L. E. Boerboom, and G. N. Olinger
Age and protection of the ischemic myocardium: Is alkaline cardioplegia appropriate?
Ann. Thorac. Surg., March 1, 1993; 55(3): 747 - 755.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Hosseinzadeh, C. I. Tchervenkov, M. Quantz, and R. C.- J. Chiu
Adverse effect of prearrest hypothermia in immature hearts: Rate versus duration of cooling
Ann. Thorac. Surg., March 1, 1992; 53(3): 464 - 471.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. J. Baker IV, G. N. Olinger, and J. E. Baker
Calcium content of St. Thomas' II cardioplegic solution damages ischemic immature myocardium
Ann. Thorac. Surg., October 1, 1991; 52(4): 993 - 999.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. E. Baker, L. E. Boerboom, and G. N. Olinger
Cardioplegia-induced damage to ischemic immature myocardium is independent of oxygen availability
Ann. Thorac. Surg., December 1, 1990; 50(6): 934 - 939.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The American Association for Thoracic Surgery.